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Abstract
Subtle behavioral and cognitive deficits have been documented in patient cohorts with orofacial clefts (OFCs). Recent
neuroimaging studies argue that these traits are associated with structural brain abnormalities but have been limited to
adolescent and adult populations where brain plasticity during infancy and childhood may be a confounding factor. Here,
we employed high resolution magnetic resonance microscopy to examine primary brain morphology in a mouse model of
OFCs. Transient in utero exposure to the Hedgehog (Hh) signaling pathway antagonist cyclopamine resulted in a spectrum
of facial dysmorphology, including unilateral and bilateral cleft lip and palate, cleft of the secondary palate only, and a non-
cleft phenotype marked by midfacial hypoplasia. Relative to controls, cyclopamine-exposed fetuses exhibited volumetric
differences in several brain regions, including hypoplasia of the pituitary gland and olfactory bulbs, hyperplasia of the
forebrain septal region, and expansion of the third ventricle. However, in affected fetuses the corpus callosum was intact
and normal division of the forebrain was observed. This argues that temporally-specific Hh signaling perturbation can result
in typical appearing OFCs in the absence of holoprosencephaly—a condition classically associated with Hh pathway
inhibition and frequently co-occurring with OFCs. Supporting the premise that some forms of OFCs co-occur with subtle
brain malformations, these results provide a possible ontological basis for traits identified in clinical populations. They also
argue in favor of future investigations into genetic and/or environmental modulation of the Hh pathway in the
etiopathogenesis of orofacial clefting.
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Introduction
Clefts of the lip with or without palate (CL/P) and cleft palate
only (CPO) are commonly occurring human birth defects that
cause significant morbidity and require extensive medical inter-
vention [1]. Even when comprehensive treatment is available,
these malformations bring significant individual, familial, and
societal burden [1,2]. The mental health of individuals born with
‘‘non-syndromic’’ orofacial clefts (OFCs) has been extensively
studied and psychosocial impairment, particularly in relation to
social interaction, has been well documented [3–5]. Cognitive
impairment, with specific deficits in verbal fluency, has also been
described [6–9]. While the majority function within the normal IQ
range, some studies have found that affected individuals score
lower than peers without clefts [7,10]. Of particular importance,
the prevalence of learning disabilities in populations with OFCs
has been observed to be nearly ten-fold higher than that of the
general population [6,9,11–13].
Conventional wisdom has held that these behavioral and
cognitive traits are secondary to the speech and hearing-related
complications frequent in this population or even to social stigma
related to physical appearance [14,15]. However, an alternative
hypothesis has been advanced, which holds that cognitive and
behavioral traits identified in populations with OFCs are, in fact, a
primary problem resulting from abnormal brain development
[16]. Recent neuroimaging studies support this premise with the
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demonstration of consistent patterns of subtle structural brain
abnormalities in adolescent and adult populations with OFCs.
These studies have found that clinical populations exhibit
disproportionate volume reductions of the frontal lobe, subcortical
nuclei, and cerebellum [16,17]. In addition to these overall size
reductions, non-uniform shifts in cerebral and cerebellar volumes
have also been found [18].
Development of the face and brain is an intimately-interrelated
process [19]. Along with serving as a structural scaffold, the brain
provides inductive molecular signals that guide development of the
adjacently developing face [20]. The Hedgehog (Hh) signaling
pathway has been identified as a key molecular mediator of brain-
face development. Sonic Hedgehog (Shh) is initially detected in the
neuroectoderm of the ventral midbrain, with expression expand-
ing caudally into the hindbrain, and rostrally into the dienceph-
alon and telencephalon. Hh signaling drives medial forebrain
expansion and induces ventral progenitor domains. Expression of
Shh in the neuroectoderm of the ventral forebrain indirectly
induces a parallel field of expression in the facial ectoderm [21],
inducing the expression of Hh target genes, including Gli1, in the
intervening neural crest-derived mesenchymal cell population.
This forebrain signaling center is critical for growth and
differentiation of the midfacial primordia [22]. Shh null mice
exhibit profound developmental defects [23], including holopro-
sencephaly (HPE), a condition defined by incomplete division of
the forebrain, characterized by medial forebrain deficiency, and
which commonly occurs with CL/P in clinical populations
[23,24]. In humans, mutations in SHH are the most commonly
identified cause of non-chromosomal HPE, accounting for
approximately 12% of such cases [25,26]. However, in a recent
analysis only 36% of SHH mutation carriers were found to have
true HPE, with the remaining carriers classified as unaffected or as
having microform HPE (i.e. facial abnormalities in the absence of
detectable neuroanatomical anomalies) [26].
When Hh signaling from the forebrain neuroectoderm is
blocked, Shh expression is not established in the facial ectoderm.
This results in attenuated growth of the frontonasal prominence,
which, in the chick, causes truncation of the upper beak [21]. In
the mouse, we have shown that temporally-specific exposure to the
Hh pathway antagonist cyclopamine results in a deficiency of the
frontonasal prominence-derived medial nasal processes, which
contribute to the philtrum of the upper lip, the alveolar ridge, the
primary palate, and the median nose. This manifests as clefts of
the lip and palate that appear to mimic human clinical phenotypes
[27].
Here, employing a refined model of cyclopamine-exposure, we
set out to determine whether Hh antagonist-induced facial
dysmorphology is associated with abnormal brain development.
High resolution magnetic resonance microscopy (MRM) was
applied for concurrent visualization and measurement of facial
and brain features, while diffusion tensor imaging was used to
visualize white matter fiber tracts. The findings described herein
illustrate that temporally-specific inhibition of the Hh signaling
pathway results in clinically-relevant facial dysmorphology in the
absence of the severe brain malformations that define HPE.
Importantly however, subtle volumetric differences were identified
in several forebrain regions of cyclopamine-exposed fetuses,
providing a potential developmental basis for characteristics
previously observed in affected clinical populations. Along with
human neuroimaging studies, these results support the premise
that some forms of typically appearing OFCs co-occur with
primary structural brain abnormalities.
Materials and Methods
Timed Mouse Mating
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
procedures involving animals were approved by the University of
North Carolina at Chapel Hill Institutional Animal Care and Use
Committee (protocol number 13–081.0). C57BL/6J mice were
purchased from The Jackson Laboratory. Two female mice were
placed with a single male for 2 hrs in the light cycle and
subsequently examined for the presence of copulation plugs,
marking gestational day (GD)0.
Cyclopamine Exposure
Cyclopamine (LC Labs) was dissolved in a sodium phosphate/
citrate buffer containing 30% (wt/wt) 2-hydropropyl-b-cyclodex-
trin and administered to timed pregnant animals by subcutaneous
infusion using Alzet (Durect) microosmotic pumps as previously
described [28]. Model 2001D pumps (227 ml volume capacity,
dispensed at 8.4 ml/h for 27 h) were loaded with cyclopamine
solution to achieve a dispensation rate of 120 mg/kg/d and
surgically implanted subcutaneously at GD8.25. Control animals
were administered vehicle alone following the same paradigm. To
assess potential effects of the surgical procedure, pump implanta-
tion, and vehicle exposure on brain development, control animals
from this study were compared to a separate control population of
GD17 C57BL/6J fetuses exposed to two intraperitoneal injections
of lactated Ringer’s solution given four hrs apart beginning at
either GD7 or GD8.5 [29]. Both control populations were
examined using the same methodology. Neither total brain
volume, nor regional volume percentages were significantly
different between the two control groups (Fig. S1).
Magnetic Resonance Imaging
On GD 17, dams were euthanized and fetuses were removed in
ice-cold phosphate-buffered saline. Following fixation in a 20:1
Bouin’s fixative:Prohance (Bracco Diagnostics) solution for
9 hours, fetuses were stored at 4uC in a 200:1 solution of
PBS:Prohance until imaging. Magnetic Resonance Microscopy
(MRM) was performed on a 9.4 T vertical bore magnet interfaced
to a GE console running Epic 12.46 (GE Medical Systems). The
system is equipped with Resonance Research gradients (Reso-
nance Research, Inc.), which achieve peak gradients of 2000 mT/
m. Two fetal heads were placed in an acrylic sample holder and
immersed in fomblin. 3D volume images were acquired in a
10 mm diameter625 mm long solenoid radiofrequency coil using
a radiofrequency refocused spin echo sequence (TR = 50 ms,
TE = 5.2 ms, field of view = 20610610 mm, matrix
size = 51262566256), resulting in isotropic spatial resolution of
39 mm. A novel acquisition strategy that amplifies the high-
frequency information by selectively altering the receiver gain
during the phase-encoding steps was applied to extend the
dynamic range of the system, capture the higher-frequency
components, and limit saturation in the central k-space [30].
Total scan time for each pair of specimens was approximately
1.1 hrs.
Brain Segmentation
Pituitary, cerebellum, and forebrain regions were manually
segmented using ITK-Snap (Version 2.1.4) as previously described
[29,31]. Automated skull-stripping [32] was used to generate
whole brain volumes as previously described [29]. As shown in
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Fig. 1, 3D reconstructions of the brain and face in situ were
generated using Slicer3 (Version 3.6.3).
Linear Measurements
Linear measurements of snout width (SW), snout length (SL),
and mandible length (ML) were obtained from 3D head
reconstructions using netfabb Studio Basic (Version 4.7). For
animals with UL-CLP, length measurements were taken from the
side of the face with the lip cleft. Length measurements were taken
from the right side for all other fetuses. Interocular distance (IOD)
measurements were captured from coronal MRM images using
ImageJ (Version 1.47t; http://rsb.info.nih.gov/ij/). Volumetric
brain measurements were obtained with ITK-Snap (Version
2.1.4).
Diffusion Tensor Imaging
On GD19, dams were euthanized and fetuses were dissected
from uterine and decidual tissue in ice-cold phosphate-buffered
saline. Head regions were subsequently removed with a scalpel,
fixed in a 20:1 Bouin’s:Prohance solution for 9 hours, then stored
at 4uC in a 200:1 solution of PBS:Prohance until imaging.
Diffusion-weighted images were acquired using an RF refocused
spin-echo pulse sequence (TR = 100 ms, TE = 11.8 ms, NEX = 1).
The acquisition matrix was 25662566512 over an 11611.22 mm
field of view yielding a Nyquist-limited isotropic voxel of 43 mm3
(voxel volume = 79 pl). Diffusion preparation was accomplished
using a modified Tanner–Stejskal diffusion-encoding scheme with
a pair of unipolar, half-sine diffusion gradient waveforms on either
side of the rf refocusing pulse. One baseline image with b = 0 (b0)
and 6 high b-value images (b = 1595 s/mm2) were acquired with
diffusion sensitization along each of 6 non-collinear diffusion
gradient vectors’ directions [1, 1, 0], [1, 0, 1], [0, 1, 1], [21, 1, 0],
[1, 0, 21], and [0, 21, 1]. Color images were produced from raw
data using DTIStudio as previously described [33].
Statistics
Multivariate analyses of variance (MANOVAs) were used to
determine significant group differences in linear and volumetric
measurements. Significant between-subject effects were followed
by Student Newman Keuls posthoc tests when appropriate. An
alpha value of 0.05 was maintained for all analyses.
Supporting Information
Validation of vehicle exposure paradigm. The control
population for this study was exposed in utero to the cyclopamine
vehicle (sodium phosphate/citrate buffer containing 30% (wt/wt)
2-hydropropyl-b-cyclodextrin) using Alzet microosmotic pumps
subcutaneously implanted in timed-pregnant dams. Total brain
volume and regional volume percentages from this control
population were compared to those of a previously described
control population exposed to a vehicle for ethanol (lactated
Ringer’s solution) by intraperitoneal injection at either GD7 or
GD8.5 [29]. Image acquisition and processing, brain segmenta-
tion, and volumetric analysis were performed using the same
methodologies for both data sets.
Gross Visualization of the Corpus Callosum. Following
fixation in Bouin’s solution, GD19 fetuses were hemisected in the
sagittal plane with a scalpel. 20 mls of undiluted Harris Modified
Hematoxylin solution was placed on the cut surface of the brain
and allowed to penetrate for 20 min. Bright-field images were
captured with a MicroPubisher 5.0 camera using QCapture Suite
software and subsequently converted to grayscale.
Results
To examine face-brain dysmorphology, GD17 fetuses exposed
to cyclopamine or vehicle alone were imaged by MRM (Fig. 1).
For each fetus, facial morphology was assessed by gross inspection
under a light microscope and examination of serial coronal MRM
images. While vehicle-exposed control fetuses were grossly normal,
facial dysmorphology was observed in each of the six cyclopamine-
exposed litters. For subsequent analyses, affected fetuses were
grouped by facial phenotype, including: unilateral cleft lip and
palate (UL-CLP; n = 10), bilateral cleft lip and palate (BL-CLP;
n = 10), cleft of the secondary palate only (CPO; n = 5), and non-
cleft (NC; n = 20) (table 1). In the NC group, midfacial hypoplasia
of varying severity was observed (Fig. 2). Relative to the vehicle-
exposed control group, snout width was reduced in the NC and
CPO groups but increased in the UL-CLP and BL-CLP groups. In
each cyclopamine-exposed group, snout length and mandible
length was decreased, while interocular distance was increased.
Primary brain morphology was then examined in MRM
sections and 3D brain reconstructions as illustrated in Fig. 3 for
Figure 1. Magnetic resonance microscopy (MRM) enables
concurrent visualization of the brain and face of GD17 mouse
fetuses. Forebrain regions, pituitary, and cerebellum were manually
segmented from transverse 39 mm MRM sections (A). 3D brain
reconstructions were generated by overlaying manually segmented
regions with whole-brain masks (B). Reduced opacity of the left cortex
and diencephalon allows visualization of the left ventricle, hippocam-
pus, third ventricle, and pituitary. From the same MRM scans, 3D head
reconstructions were created, allowing concurrent visualization of the
face and brain in situ (C–D). The size of a GD17 mouse fetus can be
appreciated when shown in scale with a U.S. penny (E).
doi:10.1371/journal.pone.0102603.g001
Table 1. Sample size by treatment group.
Treatment group Litters collected Fetuses collected Non-cleft UL-CLP BL-CLP CPO
Vehicle 5 39* 39 0 0 0
Cyclopamine 6 45 20 10** 10 5
*18 fetuses were chosen at random for imaging analysis.
**n = 3 right side UL-CLP, n = 7 left side UL-CLP.
doi:10.1371/journal.pone.0102603.t001
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representative animals from each group. Along with illustrating
normal division of the cerebral cortices in all groups, coronal
sections confirmed clefts of the secondary palate in the CPO, UL-
CLP, and BL-CLP groups. 3D reconstructions and transverse
sections illustrate normal division of the forebrain with an intact
septal region in vehicle and cyclopamine-exposed animals.
However, relative to the vehicle control, several brain regions
appear dysmorphic in cyclopamine-exposed fetuses. Indeed,
quantitative analysis revealed that total brain volume was reduced
in each of the cyclopamine-exposed groups with overt clefts, while
disproportionate changes in regional brain volumes were detected
in each of the cyclopamine-exposed groups (Fig. 4). Specifically,
pituitary volume was reduced in each of the groups, while
olfactory bulb volume was reduced in the UL-CLP and BL-CLP
groups. Increased volume of the forebrain septal region was found
in each of the cyclopamine-exposure groups, and volume of the
third ventricle was significantly increased in groups with OFCs.
These affected regions can be visualized in the transverse sections
and reconstructions shown in Fig. 3.
With its complete or partial agenesis being a hallmark
neuroanatomical feature of HPE [34,35], we next examined the
morphology of the corpus callosum in cyclopamine-exposed
fetuses with UL-CLP and BL-CLP, along with vehicle-exposed
controls. Diffusion tensor imaging was applied to generate
directionally encoded color maps of white matter fiber tracts in
GD19 fetuses. This stage was chosen because increased myelina-
tion and size facilitated better visualization of white matter fiber
tracts. In each of three fetuses with cyclopamine-induced UL-CLP
that were examined, the corpus callosum, as well as the
hippocampal and anterior commissures were present and not
grossly hypoplastic relative to the vehicle-exposed controls (Fig. 5).
This result was paralleled in three vehicle- and three cyclopamine-
exposed fetuses with BL-CLP examined by gross histological
staining (Fig. S2).
Discussion
Along with the findings of human neuroimaging studies and a
recent examination of brain morphology in Irf6 heterozygous
adult mice [36], the results presented here support the hypothesis
that some forms of OFCs co-occur with brain dysmorphology.
These largely congruent observations from clinical cohorts and
highly controlled animal models should prompt increased clinical
awareness of primary brain abnormalities that preferentially occur
in patients with OFCs. As described herein, observed abnormal-
ities of the pituitary, olfactory bulbs, and septal region may provide
an ontological basis for traits previously described in clinical
populations. One such clinical study described olfaction deficits in
adult males born with OFCs [37], while short stature has been well
characterized and linked to possible pituitary dysfunction in
affected patient populations [38–40]. While a recent study found
no significant difference in pituitary volume between adult patients
with OFCs and controls without clefts, pituitary structure and
function were not specifically examined [41]. Consistent with
Figure 3. Cyclopamine-exposed fetuses are not holoprosence-
phalic. Along with a vehicle exposed control (A, F, K), representative
examples of the cyclopamine-exposed NC (B, G, L), CPO (C, H, M) UL-CLP
(D, I, N), BL-CLP (E, J, O), groups are shown. For each example, a coronal
MRM section (A–E) showing normal separation between the cerebral
hemispheres (arrow) and the secondary palate (arrow head) is shown
above a reconstruction of the face and brain (F–J) and a transverse
section through the forebrain (K–O). Complete separation of the
cerebral hemispheres is evident in each of the reconstructed brains.
Transverse sections show normal division of the cerebral cortices with
an intact septal region. These images also illustrate deficiency of the
pituitary (arrow in G) and olfactory bulbs, and enlargement of the third
ventricle (arrow head in M) and septal region in cyclopamine-exposed
fetuses. Color-coding in F-O is shown in Fig. 1, where dark red =
cerebral cortices, light green = diencephalon, dark blue = septal
region, yellow = lateral ventricles, orange = third ventricle, pink =
olfactory bulbs, light purple = pituitary.
doi:10.1371/journal.pone.0102603.g003
Figure 2. Cyclopamine-induced facial dysmorphology. From
MRM images, extracted facial surfaces are shown for a vehicle-exposed
control fetus (A,B), along with three fetuses representative of the
phenotypic spectrum observed in the cyclopamine-exposed non-cleft
(NC) group (C–H). Snout width (SW), snout length (SL), and mandible
length (ML) were measured from facial reconstructions, while inter-
ocular distance was measured from coronal MRM sections (inset). For
each cyclopamine-exposed group, linear measurements are reported as
percent difference relative to the vehicle exposure group. Values
represent the mean + S.E.M. * p,0.05 compared to vehicle-exposed
control group.
doi:10.1371/journal.pone.0102603.g002
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increased volume of the forebrain septal region as described here,
neuroimaging studies have identified shifts in tissue distribution in
which the anterior cerebrum is enlarged [16,42]. Given the
developmental and anatomical relationship to the septum
pellucidum, the observation of septal region hyperplasia is
developmentally consistent with the finding of increased incidence
of cavum septum pellucidum in adult males with OFCs [43].
Enlargement of the third ventricle, as observed in cyclopamine-
exposed fetuses with OFCs, has been described in human clinical
populations with neurocognitive deficits, as well as in fetal mice
exposed prenatally to ethanol [29,31,44,45]. While it is thought
that ventricular enlargement may be indicative of cognitive
dysfunction, a causative relationship has not been clearly
established.
Previously, we demonstrated that the brains of mouse fetuses
with cyclopamine-induced CL/P are not grossly holoprosence-
phalic [27]. However, the throughput and resolution of the
employed methodology limited analysis to a small sample
population and was incompatible with regional brain segmenta-
tion and volumetric analysis. The imaging platform used for this
study enabled near-histologic resolution of anatomical sections and
visualization of white matter fiber tracts. With a sample size
sufficient to examine phenotypic subpopulations, we demonstrate
that the applied cyclopamine exposure paradigm results in facial
dysmorphism in the absence of the defining characteristics of
HPE. Specifically, cyclopamine-exposed fetuses exhibited separate
cerebral hemispheres, an intact corpus callosum, and a surprising
increase in forebrain septal region volume. Moreover, a slight but
significant increase in interocular distance was found in each of the
cyclopamine-exposed groups with clefts. While HPE is typically
associated with reduced interocular distance [35], clinical popu-
lations with non-syndromic OFCs have been described as
hyperteloric or as having normal interocular distance [46].
We have also shown that cyclopamine-induced cleft lip results
from a medial nasal process tissue deficiency [27]. This facial
structure receives molecular, cellular, and structural input from the
developing forebrain. While forebrain abnormalities have been
described in clinical populations with CL/P, how these may relate
to this initial pathogeneses of clefting is less clear because direct
observation of early morphogenesis in affected human embryos is
not readily done. However, several lines of evidence suggest that
the morphology of the upper lateral incisor in patients with cleft lip
provides important clues regarding the genesis of the clefting
defect. The lateral incisor has dual origins, with two distinct dental
epithelial thickenings present on the medial nasal and maxillary
processes uniting following closure of the upper lip to form this
tooth [47]. In individuals with cleft lip and palate, four distinct
upper lateral incisor patterns occur and entail each permutation of
the presence or absence of a small tooth on either side of the cleft
site. One study of primary dentition in a large sample size found
that a single tooth lateral to the cleft was present in 82% of cases
[48]. The absence of a small lateral incisor component medial to
the cleft site implies a deficiency of the medial nasal process was
operational in the pathogenesis of clefting in these individuals. The
apparent commonality of medial nasal process deficiency and
subtle forebrain abnormalities bolsters the translational potential
of the data acquired from the mouse model examined here to the
clinical condition.
In addition to technological advances, this study also benefited
from practical methodological refinements of a previously used
cyclopamine exposure paradigm [27,28]. Specifically, timed-
mating periods were reduced from overnight to two hours,
allowing for increased stage specificity, and cyclopamine was
purchased from LC Labs following in-house testing demonstrating
increased purity and solubility of the compound compared to
previously used sources. This allowed us to reduce the rate of
cyclopamine infusion to 120 mg/kg/d while maintaining terato-
genic efficacy. While circumventing dam toxicity, these refine-
Figure 4. Volumetric brain abnormalities in cyclopamine-
exposed fetuses. Total brain volumes (inset) were derived following
automated skull stripping. Values represent the mean + S.E.M. * p,0.05
compared to the vehicle-exposed control group. For determination of
disproportionate differences, the volume of each manually segmented
brain region was calculated as a percentage of total brain volume for
each animal. Remaining volume includes mid- and hindbrain regions.
To illustrate relative changes on the same scale, percent volumes are
normalized to mean control values. Values represent the mean 6 the
S.E.M. *p,0.05 compared to the control group.
doi:10.1371/journal.pone.0102603.g004
Figure 5. Corpus callosum integrity in fetuses with UL-CLP.
Diffusion tensor imaging was used to visualize white matter fiber tracts
in GD19 vehicle-exposed (top row) and cyclopamine-exposed fetuses
with UL-CLP (bottom row). For each group, one fetus was selected at
random from each of three independent litters. The directionality of the
brain fiber tracts in the color-coded maps are indicated as follows: red,
left/right; blue, inferior/superior; and green, anterior/posterior. In both
controls and cyclopamine-exposed fetuses, the corpus callosum
(dashed outline), hippocampal commissure (arrow) and anterior
commissure (arrowhead) are evident.
doi:10.1371/journal.pone.0102603.g005
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ments led to a marked increase in interlitter penetrance, with
fetuses with clefts present in all six cyclopamine-exposed litters. In
addition to previously described cleft lip and palate phenotypes,
animals with clefts of the secondary palate only were also
observed, albeit infrequently. While it is unclear how cyclopamine
exposure causes these phenotypes that are traditionally considered
disparate, a role for Hh signaling in secondary palate development
and CPO has been well described in mouse models [49].
Slightly more than half of all cyclopamine-exposed fetuses did
not present with clefts. However, the hypertelorism seen in
animals with clefts was recapitulated in this group, as were most of
the identified volumetric brain changes. Presenting with midfacial
hypoplasia, this group could be considered as having a ‘‘sub-cleft’’
phenotype, which appears to be clinically relevant. Weinberg et al.
found significant disparity between ‘‘unaffected’’ parents of
children with overt clefts, and controls, with the former exhibiting
midfacial retrusion and excess interorbital width [50]. Together,
these findings argue that clefting is not a simple binary outcome
and that intermediate phenotypes may provide important
etiological insights.
Prevention strategies for non-syndromic CL/P and CPO are
limited because our current understanding of causative factors is
inadequate. The findings presented here argue that temporally-
specific perturbation of the Hh signaling pathway results in a
spectrum of clinically-relevant facial dysmorphology, including
cleft lip and palate, cleft palate only, and a sub-cleft phenotype.
While not meeting the criteria for HPE, affected animals exhibited
subtle volumetric brain abnormalities that provide a possible
ontological basis for traits described in clinical cohorts with non-
syndromic OFCs. Taken together, these findings argue that efforts
to identify genetic and environmental Hh signaling pathway
modifiers could provide new insights and potential preventative
strategies for these common and morbid human birth defects.
Supporting Information
Figure S1 Exposure paradigm validation. The vehicle
exposure group for this study [Vehicle (cyclopamine)] was
compared to that of a previously examined control group exposed
to lactated ringers by intraperitoneal injection at GD7 or GD8.5
[Vehicle (ethanol)]. For determination of disproportionate differ-
ences, the volume of each manually segmented brain region was
calculated as a percentage of total brain volume for each animal.
To illustrate relative changes on the same scale, percent volumes
are normalized to mean control values. Values represent the mean
6 the S.E.M. Neither total brain volume (inset) nor percent
regional brain volume was significantly different between vehicle
exposure groups. *p,0.05 compared to control group.
(TIF)
Figure S2 Corpus callosum integrity in fetuses with BL-
CLP. Vehicle exposed control (top row) and cyclopamine-exposed
GD19 fetuses (bottom row) were hemisected in the sagittal plane.
The corpus callosum (dashed outline) was visualized using
concentrated hematoxylin stain. For each group, one fetus was
selected at random from each of three independent litters.
(TIF)
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